Editorial: Growth hormone treatment of "idiopathic short stature": Not so fast

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 7, 2004, Pages 3138-3139

  Freemark, Michael ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3;

BODY HEIGHT; CATCH UP GROWTH; CLINICAL TRIAL; DIET RESTRICTION; DRUG COST; DRUG MEGADOSE; EDITORIAL; FOOD AND DRUG ADMINISTRATION; GLUCOSE INTAKE; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; LOW DRUG DOSE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SHORT STATURE; STATISTICAL SIGNIFICANCE;

BODY HEIGHT; GROWTH DISORDERS; GROWTH HORMONE; HUMANS;

EID: 3242692130     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0671     Document Type: Editorial

References (14)

1. Guyda HJ 1999 Four decades of growth hormone therapy for short children: what have we achieved? J Clin Endocrinol Metab 84:4307-4316
2. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, Crowe BJ, Ross JL, Cassorla FG, Blum WF, Cutler Jr GB, Baron J on behalf of the National Institute of Child Health and Human Development-Eli Lilly and Company Growth Hormone Collaborative Group 2004 Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 89:3140-3148
3. Hebert PR, Ajani U, Cook NR, Lee I-M, Chan KS, Hennekens CH 1997 Adult height and incidence of cancer in male physicians (United States). Cancer Causes Control 8:591-597
4. Samaras TT, Elrick H, Storms LH 2003 Is height related to longevity? Life Sci 72:1781-1802
5. Ulph F, Betts P, Mulligan J, Stratford RJ 2004 Personality functioning: the influence of stature. Arch Dis Child 89:17-21
6. Kanaka-Gantenbein C, Mastorakos G, Chrousos GP 2003 Endocrine-related causes and consequences of intrauterine growth retardation. Ann NY Acad Sci 997:150-157
7. Bondanelli M, Ambrosio MR, degli Uberti EC 2001 Pathogenesis and prevalence of hypertension in acromegaly. Pituitary 4:239-249
8. LeRoith D, Roberts Jr CT 2003 The insulin-like growth factor system and cancer. Cancer Lett 195:127-137
9. Krajcik RA, Borofsky ND, Massardo ND, Massardo S, Orentreich N 2002 Insulin-like growth factor 1, IGF binding proteins and breast cancer. Cancer Epidemiol Biomarkers Prev 11:1566-1573
10. Moschos SJ, Mantzoros CS 2002 The role of the IGF system in cancer: from basic to clinical studies and clinical applications. Oncology 63:317-332
11. Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, Ekbom A, Olsen JH, Baron JA, Fraumeni Jr JF 2002 Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 13:395-400
12. Arends NJT, Lip WVD, Robben SGF, Hokken-Koelega ACS 2002 MRI findings of the pituitary gland in short children born small for gestational age (SGA) in comparison with growth hormone-deficient (GHD) children and children with normal stature. Clin Endocrinol (Oxf) 57:719-724
13. Nagel BHP, Palmbach M, Petersen D, Ranke MB 1997 Magnetic resonance images of 91 children with different causes of short stature: pituitary size reflects growth hormone secretion. Eur J Pediatr 156:758-763
14. Zenaty D, Garel C, Limoni C, Czernichow P, Leger J 2003 Presence of magnetic resonance imaging abnormalities of the hypothalamic-pituitary axis is a significant determinant of the first three years growth response to human growth hormone treatment in prepubertal children with nonacquired growth hormone deficiency. Clin Endocrinol (Oxf) 58:647-652